Bright Minds Biosciences Inc

NASDAQ:DRUG   3:59:57 PM EDT
1.08
-0.02 (-1.82%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Bright Minds Biosciences Inc Stock, NASDAQ:DRUG

19 Vestry Street, Suite 1500, New York, New York 10013
Phone: +1.647.407.2515
Number of Employees:

Description

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in developing therapeutics to improve the lives of patients with severe and life-altering diseases. Bright Minds is creating new chemical entities as targeted therapeutic agents for treatment of disorders where a serotonin (5-HT) receptor (either 5-HT2A, 5-HT2C or 5-HT2A/C) driven mechanism is the underlying pathology. These targeted neurocircuit disorders include neuropsychiatric, neurodegenerative, neuroinflammatory, and pain disorders. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in New York, NY.